Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG: 0874)

Guangzhou Baiyunshan Pharmaceutical Holdings Company Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	47,831	49,079	52,405	63,956	53,019	61,854
Market Cap Growth	-0.18%	-6.35%	-18.06%	20.63%	-14.28%	-2.46%
Enterprise Value	46,022	42,709	43,602	50,515	43,391	54,761
Last Close Price	18.08	20.46	20.93	19.70	16.19	22.03
PE Ratio	7.75	7.44	7.59	7.02	7.60	10.04
PS Ratio	0.35	0.59	0.65	0.75	0.72	0.85
PB Ratio	0.73	1.21	1.38	1.66	1.58	2.13
P/FCF Ratio	22.73	18.00	8.26	11.79	-153.25	21.08
P/OCF Ratio	19.26	10.86	6.62	9.18	76.29	11.01
EV/Sales Ratio	0.54	0.51	0.54	0.60	0.59	0.75
EV/EBITDA Ratio	8.55	7.51	7.71	9.37	10.70	12.55
EV/EBIT Ratio	10.63	8.52	8.60	10.37	12.07	13.91
EV/FCF Ratio	35.59	15.66	6.87	9.31	-125.42	18.67
Debt / Equity Ratio	0.37	0.33	0.36	0.32	0.34	0.26
Debt / EBITDA Ratio	2.88	2.20	2.30	2.14	2.60	1.62
Debt / FCF Ratio	12.00	4.83	2.14	2.25	-32.82	2.54
Asset Turnover	0.99	0.99	1.01	1.10	1.06	1.20
Inventory Turnover	6.04	5.53	5.45	5.53	5.33	5.64
Quick Ratio	1.09	1.17	1.20	1.27	1.23	1.20
Current Ratio	1.46	1.55	1.53	1.64	1.62	1.57
Return on Equity (ROE)	9.73%	12.11%	13.09%	13.33%	11.41%	14.01%
Return on Assets (ROA)	3.18%	3.71%	3.98%	3.94%	3.24%	4.06%
Return on Capital (ROIC)	4.85%	6.03%	6.45%	6.28%	5.37%	7.09%
Earnings Yield	7.25%	9.10%	8.56%	7.14%	6.53%	5.77%
FCF Yield	2.47%	5.56%	12.11%	8.48%	-0.65%	4.74%
Dividend Yield	4.74%	4.03%	3.95%	4.28%	3.95%	2.99%
Payout Ratio	46.58%	39.09%	37.58%	34.03%	44.25%	32.79%
Buyback Yield / Dilution	-0.01%	-	-	-	-	-
Total Shareholder Return	4.73%	4.03%	3.95%	4.28%	3.95%	2.99%

Source: S&P Capital IQ. Standard template. Financial Sources.